• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变检测策略的成本效益

Cost-effectiveness of strategies for detecting diabetic retinopathy.

作者信息

Dasbach E J, Fryback D G, Newcomb P A, Klein R, Klein B E

机构信息

Department of Industrial Engineering, University of Wisconsin-Madison 53706.

出版信息

Med Care. 1991 Jan;29(1):20-39. doi: 10.1097/00005650-199101000-00003.

DOI:10.1097/00005650-199101000-00003
PMID:1898753
Abstract

A computer model has been developed to determine cost-effectiveness of screening and treatment for diabetic retinopathy from a societal viewpoint. This model was used to evaluate biannual and annual screening programs using ophthalmoscopy, fundus photography with a "nonmydriatic camera," and photography with a "mydriatic camera." Computations were performed for three subpopulations formed by patients with younger onset diabetes (age at diagnosis less than 30 years) of 5 years or more duration, with older onset diabetes (age at diagnosis greater than or equal to 30 years) who are taking insulin, and with older onset diabetes not taking insulin. Population characteristics are from a well-described southern Wisconsin population where data are available, but the computer model may be specialized to other population. Generally costs of screening programs appear to be recovered by avoided costs of blindness in the population subgroups taking insulin; however, the cost of screening programs generally are not recovered by avoiding costs of blindness in the older onset population subgroup not taking insulin. It was estimated that supplying annual examination with mydriatic fundus photography as a screening program to a cohort of 1,000 diabetics from the younger onset population who have been diagnosed at least 5 years and who are currently not receiving care might save 319 sight years over the lifetime of the cohort. This program will save 62 sight years in an older onset cohort who are taking insulin, and 21 sight years in the older onset population not taking insulin (all benefits are presented as present values computed with an annual discount rate of 5%). Other programs achieve slightly lower savings in each subpopulation.

摘要

已开发出一种计算机模型,用于从社会角度确定糖尿病视网膜病变筛查和治疗的成本效益。该模型用于评估使用检眼镜、配备“免散瞳相机”的眼底摄影以及配备“散瞳相机”的摄影进行的半年一次和每年一次的筛查项目。对三个亚人群进行了计算,这三个亚人群分别由糖尿病发病年龄较轻(诊断时年龄小于30岁)且病程达5年或更长时间的患者、正在使用胰岛素的糖尿病发病年龄较大(诊断时年龄大于或等于30岁)的患者以及未使用胰岛素的糖尿病发病年龄较大的患者组成。人群特征来自威斯康星州南部一个描述详尽且有数据可用的人群,但该计算机模型也可针对其他人群进行专门化设置。一般来说,在使用胰岛素的人群亚组中,筛查项目的成本似乎可通过避免失明成本而得以收回;然而,在未使用胰岛素的老年发病人群亚组中,筛查项目的成本通常无法通过避免失明成本而收回。据估计,为一组1000名来自发病年龄较轻人群、已被诊断至少5年且目前未接受治疗的糖尿病患者提供每年一次的散瞳眼底摄影筛查项目,在该队列的一生中可能节省319个视力年。该项目将在使用胰岛素的老年发病队列中节省62个视力年,在未使用胰岛素的老年发病人群中节省21个视力年(所有效益均以5%的年贴现率计算的现值呈现)。其他项目在每个亚人群中实现的节省略低。

相似文献

1
Cost-effectiveness of strategies for detecting diabetic retinopathy.糖尿病视网膜病变检测策略的成本效益
Med Care. 1991 Jan;29(1):20-39. doi: 10.1097/00005650-199101000-00003.
2
Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.基于远程医疗的数字视网膜成像与标准眼科评估在糖尿病视网膜病变评估中的比较
Conn Med. 2012 Feb;76(2):85-90.
3
Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies.糖尿病视网膜病变筛查:替代方式与策略的相对成本效益分析
Health Econ. 1992 Apr;1(1):39-51. doi: 10.1002/hec.4730010107.
4
Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.糖尿病性视网膜病变。失明的筛查与预防。博士论文。
Acta Ophthalmol Scand Suppl. 1997(223):1-76.
5
Screening for diabetic retinopathy: the utility of nonmydriatic retinal photography in Egyptian adults.糖尿病视网膜病变筛查:非散瞳视网膜摄影在埃及成年人中的应用价值
Diabet Med. 1998 Sep;15(9):783-7. doi: 10.1002/(SICI)1096-9136(199809)15:9<783::AID-DIA634>3.0.CO;2-5.
6
Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model.
Ophthalmology. 1990 Apr;97(4):483-94; discussion 494-5. doi: 10.1016/s0161-6420(90)32573-3.
7
Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy.糖尿病视网膜病变自动远程视网膜筛查项目评估
JAMA Ophthalmol. 2016 Feb;134(2):204-9. doi: 10.1001/jamaophthalmol.2015.5083.
8
Cost-effectiveness of detecting and treating diabetic retinopathy.糖尿病视网膜病变检测与治疗的成本效益
Ann Intern Med. 1996 Jan 1;124(1 Pt 2):164-9. doi: 10.7326/0003-4819-124-1_part_2-199601011-00017.
9
Preventing diabetes blindness: cost effectiveness of a screening programme using digital non-mydriatic fundus photography for diabetic retinopathy in a primary health care setting in South Africa.预防糖尿病致盲:在南非基层医疗环境中使用数字免散瞳眼底照相术筛查糖尿病视网膜病变的成本效益。
Diabetes Res Clin Pract. 2013 Aug;101(2):170-6. doi: 10.1016/j.diabres.2013.05.006. Epub 2013 Jun 22.
10
The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography.单视野非散瞳单色数字眼底摄影结合远程图像解读用于糖尿病视网膜病变筛查的敏感性和特异性:与检眼镜检查及标准化散瞳彩色摄影的比较
Am J Ophthalmol. 2002 Aug;134(2):204-13. doi: 10.1016/s0002-9394(02)01522-2.

引用本文的文献

1
Detection Rate of Diabetic Retinopathy Before and After Implementation of Autonomous AI-based Fundus Photograph Analysis in a Resource-Limited Area in Belize.在伯利兹一个资源有限地区实施基于人工智能的自主眼底照片分析前后糖尿病视网膜病变的检出率
Clin Ophthalmol. 2025 Mar 21;19:993-1006. doi: 10.2147/OPTH.S490473. eCollection 2025.
2
MicroRNAs (-146a, -21 and -34a) are diagnostic and prognostic biomarkers for diabetic retinopathy.微小 RNA(-146a、-21 和 -34a)是糖尿病视网膜病变的诊断和预后生物标志物。
Biomed J. 2021 Dec;44(6 Suppl 2):S242-S251. doi: 10.1016/j.bj.2020.11.003. Epub 2020 Nov 4.
3
Optimal screening schedules for disease progression with application to diabetic retinopathy.
疾病进展的最佳筛查时间表及其在糖尿病视网膜病变中的应用。
Biostatistics. 2018 Jan 1;19(1):1-13. doi: 10.1093/biostatistics/kxx009.
4
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.1型糖尿病视网膜病变循证筛查的频率
N Engl J Med. 2017 Apr 20;376(16):1507-1516. doi: 10.1056/NEJMoa1612836.
5
Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.糖尿病视网膜病变临床实践指南:针对伊朗人群定制
J Ophthalmic Vis Res. 2016 Oct-Dec;11(4):394-414. doi: 10.4103/2008-322X.194131.
6
Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities.不同糖尿病视网膜病变筛查方式的成本效益
J Diabetes Sci Technol. 2015 Dec 29;10(2):301-7. doi: 10.1177/1932296815624109.
7
Using Markov Chains to predict the natural progression of diabetic retinopathy.使用马尔可夫链预测糖尿病视网膜病变的自然进展。
Int J Ophthalmol. 2015 Feb 18;8(1):132-7. doi: 10.3980/j.issn.2222-3959.2015.01.25. eCollection 2015.
8
Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.将糖尿病视网膜病变筛查间隔延长至1年以上:系统评价
Br J Ophthalmol. 2016 Jan;100(1):105-14. doi: 10.1136/bjophthalmol-2014-305938. Epub 2015 Jan 13.
9
Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy.分析糖尿病视网膜病变患者激光治疗不依从的原因。
Can J Ophthalmol. 2013 Apr;48(2):88-92. doi: 10.1016/j.jcjo.2012.09.012.
10
Role of early screening for diabetic retinopathy in patients with diabetes mellitus: an overview.糖尿病患者糖尿病视网膜病变早期筛查的作用:综述
Indian J Community Med. 2011 Oct;36(4):247-52. doi: 10.4103/0970-0218.91324.